2010 – Present
| June 2023 | University of Haifa, Israel | The Immuno-tolerant Microenvironment of Liver metastases: Challenges and Opportunities - Invited lecture |
| June 2023 | Liver Metastasis Research Network- Brussels, Belgium | The need for a multidisciplinary approach of liver metastasis |
| March 2023 |
IGF and Insulin System in Physiology and Disease - Gordon Research Conference- Ventura, California, USA |
Targeting the IGF Axis in Pediatric and Adult Glioma -ÌýInvited lecture |
| June 2022 | Liver Metastasis Research Network- Sheffield UK | The microenvironment of liver metastases: biology and clinical implications- Session Chair and Introductory lecture |
|
June 2022 |
Pancreatic Cancer UK Discovery and Translational Research Forum, University of Oxford, Oxford, UK | The immune-tolerant micro-environment of liver metastases - challenges and opportunities |
|
May 2021 |
Liver Metastasis Research Network – Virtual Meeting, Montreal, Canada | Combinatorial immunotherapy for PDAC liver metastases - insights from animal models. |
| March 2021 | The Ohio State University Comprehensive Cancer Center James Cancer Hospital and Solove Research Institute, Columbus, Ohio - Virtual meeting | Invitation to speak at Grand Rounds Series for the 2019-20 season. Visit rescheduled due to travel restrictions |
| December 2020 | Liver Metastasis Research Network – Virtual Meeting, Montreal, Canada | The microenvironment of liver metastases – an overview. |
| November 2018 | Presentations to Pfizer | Presentation 1: Novel target and potential biomarker for pancreatic ductal adenocarcinoma therapy. Presentation 2: Targeting invadopodia for blockade of cancer cell invasion and metastasis: role of chemokine signaling. |
| June 2018 | AACR conference on Cancer Dormancy and Residual Disease, Montreal, Canada | Glioma cells with downregulated IGF-IR expression can persist in the brain in a dormant state |
| June 2018 | Liver Metastasis Research Network – Annual Meeting, Montreal, Canada | Targeting the immune microenvironment of PDAC metastases |
| December 2017 | Annual Research day of the Centre for Excellence in Translation Immunology, Montreal, Canada | Sex disparity in the regulation of the immunosuppressive microenvironment of liver metastases |
| June 2017 | Liver Metastasis Research Network – Annual Meeting, Rotterdam, Netherlands | Collagen IV-conveyed signals regulate an EMT program and promote expansion of liver-metastases |
| November 2016 | The 8th International Congress of the GRS and IGF Society | An IGF-Trap inhibits spontaneous liver metastasis of pancreatic ductal adenocarcinoma |
| June 2016 | Liver Metastasis Research Network – 2016 Annual Meeting, Umea, Sweden | Lecture title 1: Type IV collagen conveyed signals can alter chemokine expression and tumour cell interactions with the liver microenvironment. Lecture title 2: Inhibition of liver metastases from colon and pancreatic cancers by the IGF-Trap - an update. |
| April 2016 | Oncology Lecture, Saint Mary’s Hospital, Montreal, Canada | Role of the microenvironment in liver metastasis: from pre- to pro-metastatic niches |
| March 2016 | The ÎÛÎÛ²ÝÝ®ÊÓƵ Students' Chapter of the Canadian Liver Foundation | Role of the microenvironment in liver metastasis |
| June 2015 | Liver Metastasis Research Network – 2015 Annual Meeting, Madrid, Spain | The role of the IGF axis in liver metastasis |
| June 2015 | EACR-AACR-SIC 2015 Special Conference, Florence, Italy | Regulation of the immunosuppressive microenvironment of liver metastases by TNFR2 |
| July 2014 | University of California, San Diego | Origin, regulation and function of hepatic stellate cells in colorectal cancer liver metastasis |
| November 2013 | Colorectal Cancer Association of Canada - Montreal, Canada | Personalised medicine in the management of colorectal cancer. (Session Chair) |
| June 2013 | International meeting of the Liver Metastasis Research Network - Montreal, Canada | Role of the microenvironment in liver metastasis. |
| October 2012 | The 40th annual meeting of the International Society of Oncology and Biomarkers - Jerusalem, Israel | An IGF-Trap for the treatment of Cancer. |
| March 2012 | Conference on the Biology of Liver Metastasis - Copenhagen, Denmark | Role of the microenvironment in liver metastasis. |
| November 2011 | The 5th China Medicinal Biotech Forum – Beijing, China | Developing an IGF-I receptor decoy as an anti-cancer drug. – Keynote speaker |
| June 2011 | Montreal International Symposium on Angiogenesis and Metastasis (MISAM) | The molecular landscape of liver-specific metastasis – What have we learnt. |
| May 2011 | Crossroad for BioTransfer 2011 - NRC Biotechnology Research Institute | Soluble IGF-I receptor for treatment of cancer and metastasis |
| February 2011 | Gordon Research conference on Insulin-like Growth factors in Physiology and Disease - Ventura, Ca. USA | Multipronged regulation of the tumor microenvironment by the IGF axis. |
| August 2010 | 15th International Symposium of the International Society of Cells of the Hepatic Sinusoids | Distinct and gender-specific roles of the TNF receptors in liver metastasis. |
| July 2010 | Quebec-Israel Joint Colloquium on Drug Discovery and Development - Jerusalem, Israel | Developing an IGF Trap for cancer therapy: Progress and Challenges. |
| May 2010 | 5th Canadian Gene therapy and Vaccine Symposium - Lac Carling, Canada | Use of an IGF-Trap for Cancer Therapy. |
Ìý